Lapatinib and Bevacizumab for Metastatic Breast Cancer

NCT00444535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: lapatinib
DRUG: bevacizumab

Sponsor

Novartis Pharmaceuticals